Supplementary Data from FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy

Authors:
  • DPDonna Przepiorka
    Donna Przepiorka
  • RLRobert Q. Le
    Robert Q. Le
  • AIAlexei Ionan
    Alexei Ionan
  • YWYing-Hong Wang
    Ying-Hong Wang
  • RGRamadevi Gudi
    Ramadevi Gudi
  • SMSoumya Mitra
    Soumya Mitra
  • OOOlanrewaju O. Okusanya
    Olanrewaju O. Okusanya
  • LMLian Ma
    Lian Ma
  • YYYuching Yang
    Yuching Yang
  • PPParesma Patel
    Paresma Patel

Abstract
Supplementary Data from FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy